Deal Library / Pharma BD Deal Intelligence

Bayer AG — Pharma Deals

The Pharma Closeout tracks 24 deals, $139.5B in disclosed deal value, 12 with a post-close Outcome Score for Bayer AG.

Median Critic Score: 79  ·  Median Outcome Score: 52

Best outcome: Bayer AG / Schering AG (79)  ·  Weakest outcome: Bayer AG / Monsanto Company (35)

All 24 deals

• Bayer AG / Schering AG — 2006 · $21.5B · Worked — the deal delivered on its rationale.
• Bayer AG / BlueRock Therapeutics — 2002 · $600M · Worked — the deal delivered on its rationale.
• Bayer AG / Merck & Co., Inc. — 2014 · $14.2B · Largely worked — most objectives met.
• Bayer AG / Schering AG (residual squeeze-out) — 2007 · $985M · Largely worked — most objectives met.
• Bayer AG / Arvinas, Inc. — 2019 · $1.0B · Mixed — partial payoff, real shortfalls.
• Bayer AG / Merck & Co. Inc. — 2014 · $14.2B · Mixed — partial payoff, real shortfalls.
• Bayer AG / Asklepios BioPharmaceuticals — 2020 · $2.0B · Mixed — partial payoff, real shortfalls.
• Bayer AG / Viralgen — 2020 · Mixed — partial payoff, real shortfalls.
• Bayer AG / Cutter Laboratories — 1974 · Mixed — partial payoff, real shortfalls.
• Bayer AG / Algeta ASA — 2002 · $2.9B · Mixed — partial payoff, real shortfalls.
• Bayer AG / Algeta ASA — 2013 · $2.9B · Underwhelmed — fell short of the thesis.
• Bayer AG / Monsanto Company — 2016 · $63.0B · Underwhelmed — fell short of the thesis.
• Bayer AG / Perfuse Therapeutics, Inc. — 2026 · $2.5B
• Bayer AG / Dewpoint Therapeutics Inc. — 2024 · $424M
• Bayer AG / Mammoth Biosciences Inc. — 2022 · $1.0B
• Bayer AG / Vividion Therapeutics, Inc. — 2021 · $2.0B
• Bayer AG / Asklepios BioPharmaceutical, Inc. (AskBio) — 2020 · $4.0B
• Bayer AG / Recursion Pharmaceuticals, Inc. — 2020 · $1.1B
• Bayer AG / KaNDy Therapeutics Ltd. — 2019 · $875M
• Bayer AG / BlueRock Therapeutics LP — 2019 · $600M
• Bayer AG / Loxo Oncology, Inc. — 2017 · $1.6B
• Bayer AG / Schiff Nutrition International, Inc. — 2012 · $1.2B
• Bayer AG / Onyx Pharmaceuticals — 2011 · $160M
• Bayer AG / Algeta ASA — 2009 · $800M

← Deal Library  ·  Interactive search  ·  How we score deals